Babcock To Buy Remaining 50% Stake In Australian JV For A$60 Mln

By RTTNews Staff Writer ✉ | Published: 2/15/2022 2:52 AM ET

Babcock International Group Plc (BAB.L) a British aerospace, defense, and nuclear engineering services provider, said on Tuesday that it has inked a deal to acquire the remaining 50 percent interest in its Australian Naval Ship Management or NSM joint venture or JV, from its partner in Australia, for a consideration of A$60 million, or around 32 million pounds.

Founded in 2012, the NSM JV is aimed at to maintain of the Royal Australian Navy's ANZAC class frigates. However, today the business has evolved into a strategic maritime sustainment partner to Australia.

For the year to March 31, 2021, NSM reported A$254 million in revenues.

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Editors Pick

United Airlines, Archer To Launch First Air Taxi Route In Chicago

United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route.

Aunt Millie's Our Family White Hot Dog Buns Recalled

Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie.

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.

Latest Updates on COVID-19

34% Fall In US Covid Cases, 38% Fall In Deaths In Last 2 Weeks

Biden Signs Covid Origins Bill Into Law

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

Covid Cases, Hospitalizations Fall Nationwide In Last 2 Weeks

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

COVID-19: Drugs in Development

Follow RTT

Most Read
Most Emailed

Babcock To Buy Remaining 50% Stake In Australian JV For A$60 Mln

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update

FDA Clears Eat Just's Good Meat Cultivated Chicken

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Dyne Therapeutics Announces Orphan Drug And Rare Pediatric Designations For DYNE-251

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

Generation Bio Shares Surge On Partnership With Moderna

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

Biogen Updates On FDA Advisory Committee Meeting On Tofersen For SOD1-ALS

FDA Approves Incyte's Zynyz For Skin Cancer Treatment

Pendragon FY22 Earnings Drop, But Revenue Climbs; Says Confident Of FY23

Kingfisher FY Adj. Post-tax Profit Declines; LFL Sales Down 2.1%

Playtech FY22 Profit Down, Revenues Rise; Says Strong Start To FY23

Biogen Updates On FDA Advisory Committee Meeting On Tofersen For SOD1-ALS

Heidelberg Materials Lifts Annual Dividend

Kite Reports Primary Overall Survival Analysis Results Of Phase 3 ZUMA-7 Study

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

Iovance Biotherapeutics Completes BLA Submission For Lifileucel In Advanced Melanoma

Canadian Solar Inc. Q4 Income Rises

Trupanion CFO Drew Wolff To Step Down Effective June 1

HORNBACH Group FY Adj. EBIT To Decrease By Approx. 20%; Group Sales Up 6.6%

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update